Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

VUMC, VU University Medical Centre

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis
M Vis, E A Havaardsholm, G Haugeberg, T Uhlig, A E Voskuyl, R J van de Stadt, B A C Dijkmans, A D Woolf, T K Kvien, W F Lems

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1495-1499; DOI: 10.1136/ard.2005.044198